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Partial  immunologic  tolerance,  which  is  produced  by  antigen  treatment  of 
newborn  or  adult  guinea  pigs,  is  manifested  by  depressed  or  absent  delayed 
hypersensitivity  in  animals  which  produce  normal  amounts  of  certain  classes 
of antibodies  (1-4).  In  the  present  studies,  the  cellular  basis  of partial  toler- 
ance was investigated  utilizing  in vitro techniques.  Normally,  peritoneal  exu- 
date  cells  (PEC) I  obtained  from  sensitized  guinea  pigs  are  inhibited  from 
migrating  out of capillary tubes by sensitizing  antigen  (5, 6). The inhibition  of 
migration  is  due  to  a  soluble  material,  migration  inhibitory  factor  (MIF), 
which is elaborated  by sensitized  lymphocytes in contact with the  appropriate 
antigen  (7,  8).  We found  that  peritoneal  exudate  cells from partially  tolerant 
guinea pigs behave  as cells from nonsensitized  animals,  i.e.  their migration  is 
not affected by addition  of the tolerance-inducing  antigen.  This lack of in vitro 
responsiveness  of  peritoneal  exudate  cells  from  partially  tolerant  animals  is 
accompanied  by a  failure  of their  lymphocytes  to  elaborate  MIF  when  incu- 
bated with the tolerance-inducing  antigen. 
Materials and Methods 
Animals.--Newborn  and adult Hartley strain guinea  pigs weighing 400-600  g were used 
for the induction  of partial tolerance or sensitization.  Albino guinea pigs weighing 250-350 g 
were used for passive cutaneous  anaphylaxis. 
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603 604  SUPPRESSION  OF  DELAYED HYPERSENSITIVITY 
Antigens.--2,4-Dinitrophenylsulfonic  acid  (DNPS)  (Eastman  Kodak  Co.,  Rochester, 
N. Y.), twice recrystallized, was coupled to bovine plasma albumin (BPA)  (Armour Pharma- 
ceutical Co.,  Kankakee, Ill.)  and  q~-chlorobenzoyl chloride  (OCBC)  (Eastman Kodak  Co.) 
was coupled to bovine gamma globulin (BGG)  as previously described (9, i0). Briefly,  500 mg 
of BGG was dissolved in 50 ml of distilled water containing 5 ml of 5% Na2CO~. To this was 
added, drop by drop, 2 ml of a mixture containing 0.4 m] of OCBC in 7.6 ml of dioxane.  This 
mixture was centrifuged and 1 N HC1 was added to the supernatant until a maximum precipi- 
tate was obtained. After incubation for about 3 hr at room temperature, the precipitate was 
spun down and resuspended in a small volume of distilled water. The precipitate was brought 
into solution by adding 1 N NaOH. It was then extensively dialyzed with distilled water made 
alkaline to pH of 7.8-8.0 with Na2CO3. 
Induction  of Partial  Tolerance in Adult Guinea  Pigs.--Adult  animals were treated with a 
total of 468 mg/kg of OCBC-BGG in saline given subcutaneously in eight equal daily doses. 
After a rest period of 3 wk, the animals were injected with 200 #g of OCBC-BGG, and 200 #g 
of DNP-BPA. Both antigens were mixed 1  : 1 with complete Freund's adjuvant (Difco H37Ra), 
and each animal received a total volume of 0.4 ml, 0.1 ml/footpad. For controls, animals not 
treated with OCBC-BGG in saline were injected with the two antigens in complete Freund's 
adjuvant. 
Induction  of Tolerance in Adult Guinea  Pigs with a Single  Intravenous  Dose of Aggregate- 
Free Antigen.--A  solution of OCBC-BGG or DNP-BPA (18-30  mg/ml) in 0.15 M NaCI was 
centrifuged at 40,000 rpm in a Spinco Model L using a No. 40 rotor. 10 animals were injected 
intravenously with 1 ml (23.3 mg/ml) of the supernatant, which was presumed to be aggre- 
gate-free OCBC-BGG  and  10  animals were similarly injected with  1 ml  (17.7 mg/ml)  of 
supernatant, aggregate-free DNP-BPA. All these animals, together with untreated controls, 
were injected with OCBC-BGG and DNP-BPA in complete Freund's adjuvant, as described 
above, immediately after the intravenous antigen injection. 
Induction of Tolerance in Newborn Animals.--Guinea pigs were injected peritoneally during 
the 1st wk of life with a total of 32 mg of DNP-BPA divided into eight equal daily doses. After 
a  rest period of 3  wk,  these animals,  together with noninjected control litter mates, were 
injected with 200 #g of DN-P-BPA and 200 #g of OCBC-BGG in complete Freund's adjuvant 
as above. 
Skin Tests.--All animals were skin tested with 50/zg of each antigen in saline 10 days after 
their sensitization with antigen in complete Freund's adjuvant. Readings were made 24 hr 
later. 
Antibody Determination.--At the time of the in vitro studies the animals were bled and their 
sera assayed by passive hemolysis for 72  antibody  and  by quantitative passive cutaneous 
anaphylaxis (PCA) for "n antibody (11, 12). 
In Vitro Test for Cellular Hypersemitivfty.--Peritoneal  exudate cells from normal, sensitized, 
and tolerant guinea pigs were induced by an intraperitoneal injection of light mineral oil 2 wk 
after the skin test, and collected as previously described (9,  13). The cells were washed in 
balanced salt solution and made to a 10% suspension by volume in Eagle's minimum essential 
medium  s with 15% normal guinea pig serum, 85 units of penicillin/ml, and 85/zg of strepto- 
mycin/ml. Capillary tubes were filled with the cell suspension, sealed with wax, and centri- 
fuged. The tubes were cut  and the portion containing the cells placed in  Mackaness-type 
chambers, two per chamber. Cells from each animal were assayed as follows: two chambers 
for each of the antigens and two chambers with media, but no antigens. The antigen concen- 
tration was 100 #g/ml. 
The chambers were incubated for 19 hr at 37°C and the area of migration was measured by 
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following formula was used: 
Average migration with antigen 
X  100  =  per cent migration. 
Average migration with no antigen 
Production of Migration Inhibitory  Factor.--Lymphocytes,  obtained  by  teasing regional 
lymph nodes from guinea pigs sensitized with antigen in complete Freund's adjuvant, were 
incubated in minimum essential medium (Eagle's) without serum at a concentration of 2.4 X 
107 cells/ml with and without specific antigen (100 #g/ml). After 24 hr of incubation, the cell 
suspensions were centrifuged at 12,000 rpm, and the supernatants removed and made to con- 
tain 15% guinea pig serum_ The supernatants were tested for MIF activity (8). 
RESITLTS 
Macrophage Migration  Inhibition  Assay  Using  Cells of Animals  in  Which 
Delayed Hypersensitivity was Suppressed In Viw.--Adult guinea pigs pretreated 
with  large  intravenous  or  subcutaneous  doses  of OCBC-BGG  in  saline  and 
subsequently injected with this antigen and an unrelated antigen, DNP-BPA, 
in complete Freund's adjuvant had markedly diminished delayed hypersensi- 
tivity to OCBC-BGG. However, delayed hypersensitivity to DNP-BPA was 
unimpaired.  In  addition,  ~'2  antibody formation to OCBC-BGG was  dimin- 
ished or suppressed, while ~1 antibody formation remained unaffected. Similar 
results were obtained regardless of whether tolerance was induced by neonatal 
injection,  by multiple doses of antigen  given subcutaneously,  or by a  single 
dose of aggregate-free antigen given intravenously. Results of skin tests  and 
antibody titers on animals that were further studied by the in vitro assay are 
shown in Table I. 
Peritoneal exudate cells  from animals with suppressed  delayed hypersensi- 
tivity skin tests to OCBC-BGG were assayed in vitro with that  antigen and 
with the unrelated antigen, DNP-BPA. The results of these experiments can 
be seen in Table II. The peritoneal exudate cells from each of the  10 experi- 
mental animals were not inhibited from migrating in vitro by OCBC-BGG, the 
antigen used to suppress delayed hypersensitivity in vivo; the average migra- 
tion of cells from these animals was  112.4%.  In contrast, peritoneal exudate 
cells from the same 10 experimental animals were readily inhibited in vitro by 
the unrelated antigen (DNP-BPA), which also elicited delayed hypersensitiv- 
ity in vivo; the average migration in the presence of this antigen was 46.1%. 
The peritoneal exudate cells of control animals  that  were sensitized to both 
antigens  were inhibited in vitro by both antigens.  The average migration of 
control cells was  45.5%  with  OCBC-BGG and 35.5%  with DNP-BPA.  The 
peritoneal exudate cells  of normal,  nonsensitized  animals  were not  inhibited 
from migrating by either antigen. Similar results were obtained in experiments 
using DNP-BPA to suppress delayed hypersensitivity and OCBC-BGG as the 
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toneal  cells of four animals  was  105 %  with DNP-BPA  and 57 %  with OCBC- 
BGG. 
Experiments  with  Migration  Inhibitory  Factor.--These  experiments  were 
TABLE I 
Partial Tolerance: Results of Skin Tests and Antibody Formation 
Animal  s 
Antibody formation to 
Skin tests  OCBC-BGG 
OCBC-BGG  DNP-BPA 
vzpassive 
lysis logs  ~lPCAlog~ 
titer  titer 
Experimental*:  mm  mm 
1  5X6,  20X25  0  10 
14  8X6  20>(25  0  10 
85  0  10Xl0  0  9 
94  7)<6  18X19  4  11 
95  5 X  5  20X17  0  11 
96  10X7  22X25  5  11 
29§  6X6  16X  18  4  11 
32  6X6  20X20  4  11 
34  8X8  15X20  5  11 
40  7X  7  20X20  4  11 
Controlll 
52  15X  15  15X  15  6  8 
55  20X25  15X  15  6  8 
lc  11X  12  22X  15  6  9 
2c  20 X  20  18 X  17  8  11 
3c  15 X  16  15 X  20  8  11 
Oc  15 X  15  13 X  18  7  11 
37¶  15 X  15  20 X  20  7  11 
43  15 X  15  20 X  20  6  10 
48  20 X  15  15 X  15  6  10 
* Experimental animals 1-96 made partially tolerant by multiple subcutaneous injections 
of antigen. 
:~ Average skin tests of 10 normal unsensitized animals with 50 #g OCBC-BGG (4 X  6 mm) 
(2 animals 0 X  0 mm; 1 animal 8 X  12 mm). 
§ Experimental animals 29-40 made partially tolerant by a single intravenous injection of 
aggregate-free antigen. 
[] Control animals for experimental animals  1-96. 
¶  Control animals for experimental animals 29-40. 
designed  to  determine  if  an  alteration  in  the  behavior  of  macrophages  or 
lymphocytes  was  responsible for the  absence  of inhibition  of migration by the 
antigen  used  to  induce  tolerance.  The  finding  that  macrophages  of  animals 
tolerant  to  one  antigen  (OCBC-BGG)  were  inhibited  by  another  antigen YVES  BOREL  AND  JOHN  R.  DAVID  607 
(DNP-BPA),  to which the animals also displayed delayed hypersensitivity in 
vivo,  demonstrated  that,  at  least  to  this  second  antigen,  the  macrophages 
respond normally in vitro, i.e. they could be inhibited by IVIIF  produced when 
TABLE II 
Partial Tolerance Studied by In Vitro Inhibition  of Cells Migration 
Animals 
Migration 
OCBC-BCG  DNP-BPA 
%  % 
Experimental* : 
1  99  45 
14  100  50 
85  119  37 
94  104  31 
95  155  62 
96  106  28 
29~  111  33 
32  111  51 
34  88  66 
40  131  58 
Average  112.4  Average  46.1 
Control§ : 
52  45  41 
55  40  37 
lc  51  27 
2c  55  33 
3c  43  26 
0c  41  20 
48]I  39  40 
37  34  50 
43  63  46 
Average  45.5  Average  35.5 
* Experimental animals 1-96 made partially tolerant by multiple subcutaneous  injections 
of antiger~s. 
:~ Experimental animals 29-40 made partially tolerant by a intravenous single injection of 
aggregate-free  antigen. 
§ Control animals for experimental animals 1-96. 
II Control animals for experimental animals 29-40. 
DNP-BPA  sensitive  lymphocytes  reacted  with  DNP-BPA.  In  addition, 
macrophages  from  animals rendered  tolerant by neonatal  injection of DNP- 
BPA were still capable of being inhibited when incubated with MIF produced 608  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY 
by the interaction of sensitive DNP-BPA lymphocytes and DNP-BPA  (Table 
III). Of interest was the finding in two experiments that lymph node lympho- 
cytes from O CB C-B GG tolerant guinea pigs, when incubated with OCBC-B GG, 
did not produce  MIF (migration 93  and 98 %). In one experiment, it was not 
possible to detect an inhibitor  of MIF by mixing supernatants  obtained from 
OCBC-BGG tolerant lymphocytes that had been incubated with OCBC-BGG 
with  active MIF produced by sensitized OCBC-BGG cells. 
DISCUSSION 
The results  of the studies described  above indicate  that suppression of de- 
layed hypersensitivity in vivo is correlated with failure of the tolerant animal's 
lymphocytes to produce MIF on exposure to the same antigen used to induce 
partial  tolerance.  Moreover,  the  suppression  of  delayed  hypersensitivity  is 
specific, whether tested in vivo or  in vitro. Peritoneal exudate cells from ani- 
TABLE III 
Inhibition of Migration of Tolerant Peritoneal Exudate Cells by MIF 
Source of  PEC 
Migration 
DNP-BPA*  MIF$ 
Normal 
Tolerant  to DNP-BPA by neonatal antigen injec- 
tion 
Sensitized to DNP-BPA 
%  % 
85  43 
75  32 
25  25 
* DNP-BPA in media, 100 #g/ml. 
:~ MIF made from DNP-BPA sensitized cells in media. 
mals  tolerant  to  one  antigen  are  readily  inhibited  from  migrating  in  vitro 
when exposed to a second unrelated  antigen to which the animal is sensitized. 
This  finding  indicates  that  the  macrophages  from  tolerant  animals  respond 
normally in vitro to MIF and suggests that they are not responsible for the 
lack of inhibition of migration observed in the presence of the antigen used to 
induce  tolerance.  This  interpretation  is  supported  by results  of experiments 
with migration inhibitory factor, which indicate that the lymphocytes are the 
cells involved in the alteration of delayed hypersensitivity reactions in tolerant 
animals. No MIF was produced when lymph node cells from partially tolerant 
animals were incubated  with the antigen  used to induce tolerance.  However, 
the migration of peritoneal exudate  cells obtained from tolerant  animals was 
inhibited  by MIF obtained from control  animals sensitized  with  the  antigen 
used to induce tolerance. The normal behavior of macrophages in these  studies 
is consistent with findings by others of normal functions  of macrophages ob- 
tained  from tolerant  animals  (14,  15,  16).  In  addition,  the  suppression  of 3'2 YVES BOREL AND JOHN R.  DAVID  609 
antibody was  also observed,  as previously reported  (1,  2).  However, there is 
no direct correlation between the suppression of delayed hypersensitivity and 
the suppression of q/2 antibody (4). 
This study shows that antigen suppression of delayed hypersensitivity results 
in  the  absence of at  least one of the  soluble mediators  of this  immune  phe- 
nomenon. The mechanism by which  induction  of partial tolerance suppresses 
production of migration inhibitory factor is unknown. 
SUMMARY 
Suppression  of delayed hypersensitivity in vivo is correlated  in vitro with 
the absence of macrophage migration inhibition in the presence of the antigen 
used to induce partial tolerance. The suppression  of delayed  hypersensitivity 
is  antigen-specific in vivo as well as in vitro.  The lymphocytes,  and  not the 
macrophages, are  the cells involved in the induction  of tolerance in terms of 
delayed  hypersensitivity which  is  characterized  by  an  absence  of migratory 
factor activity. 
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